|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0034656,
umls-concept:C0036186,
umls-concept:C0042402,
umls-concept:C0042523,
umls-concept:C0199176,
umls-concept:C0221198,
umls-concept:C0332152,
umls-concept:C0332835,
umls-concept:C0522523,
umls-concept:C0597635,
umls-concept:C1274040,
umls-concept:C1522318,
umls-concept:C1550147,
umls-concept:C1948041,
umls-concept:C2587213
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-6-3
|
|
pubmed:abstractText |
Intragraft verapamil is effective in treating no-reflow during saphenous vein graft (SVG) percutaneous coronary intervention (PCI). In this study, we assessed the use of intragraft verapamil given pre-PCI to prevent no-reflow.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1042-3931
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
299-302
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12042618-Aged,
pubmed-meshheading:12042618-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12042618-Coronary Angiography,
pubmed-meshheading:12042618-Female,
pubmed-meshheading:12042618-Graft Occlusion, Vascular,
pubmed-meshheading:12042618-Heart Catheterization,
pubmed-meshheading:12042618-Humans,
pubmed-meshheading:12042618-Male,
pubmed-meshheading:12042618-Middle Aged,
pubmed-meshheading:12042618-Myocardial Reperfusion,
pubmed-meshheading:12042618-Preoperative Care,
pubmed-meshheading:12042618-Regional Blood Flow,
pubmed-meshheading:12042618-Saphenous Vein,
pubmed-meshheading:12042618-Treatment Outcome,
pubmed-meshheading:12042618-Vasodilator Agents,
pubmed-meshheading:12042618-Verapamil
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial.
|
|
pubmed:affiliation |
University of California at San Francisco Medical Center, Division of Cardiology, 505 Parnassus Avenue, Box 0124, San Francisco, CA 94143-0124, USA. andrewm@itsa.ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
